AstraZeneca, Merck ovarian cancer treatment improves progression-free survival

AstraZeneca Plc and Merck & Co Inc said on Monday their treatment for newly diagnosed advanced ovarian

from Reuters: Health News https://ift.tt/2mcqZgV
via IFTTT